Reporter Mouse/Rat Models_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Product No	Product	Application area
112495	B-CAG-Tdtomato cKI rats	Reporter line that can be crossed with Cre-expressing strains. In presence of Cre, the floxed "stop" upstream of the TdTomato gene is deleted allowing expression of the red fluorescent TdTomato protein.
111911	B-Upar-EGFP mice
112473	B-Cd38-EGFP KI mice
111911	B-Plaur-EGFP mice	Validation of the expression and function of Plaur in diseases
111927	B-Cd155-EGFP KI mice	Validation of the function of Cd155 in the development of tumor disease
110166	B-PD-1-EGFP KI mice	Validation of the function of PD-1 in the development of tumor and autoimmune disease. Trace the functional cells in the development of tumor and autoimmune disease by the expression of EGFP.
110156	B-ROSA26-EGFP-DTA mice	Function research of genes. Deletion of specific groups of cells
110161	B-IL17a-EGFP mice	Function research of genes .This model is an efficient tool in tracking the expression pattern of IL17A with EGFP fluorescence.
110148	B-CAG-tdTomato cKI mice	This CAG-tdTomato model is an efficient tool to study the tissue specification of Cre mice, when cross with the Cre mice.

Biocytogen is headquartered in Beijing, with branches in Haimen, Jiangsu, Boston, Shanghai. Its wholly-owned subsidiary, Eucure Biopharma, focuses on clinical development.